{"name":"Teva Pharmaceutical","slug":"teva","ticker":"TEVA","exchange":"NYSE","domain":"tevapharm.com","description":"Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.","hq":"Tel Aviv, Israel","founded":0,"employees":"31173","ceo":"Richard Francis","sector":"Generics / Specialty Pharma","stockPrice":30.2,"stockChange":0.87,"stockChangePercent":2.97,"marketCap":"$36.0B","metrics":{"revenue":2469000000,"revenueGrowth":11.4,"grossMargin":51.8,"rdSpend":98000000,"netIncome":1410000000,"cash":3556000000,"dividendYield":0,"peRatio":25,"fiscalYear":"FY2025"},"revenueBreakdown":[{"name":"Austedo","genericName":"DEUTETRABENAZINE","slug":"deutetrabenazine","revenue":1100000000,"yoyGrowth":0,"percentOfTotal":44.6},{"name":"Copaxone","genericName":"GLATIRAMER ACETATE","slug":"glatiramer-acetate","revenue":700000000,"yoyGrowth":0,"percentOfTotal":28.4},{"name":"Ajovy","genericName":"FREMANEZUMAB","slug":"fremanezumab","revenue":600000000,"yoyGrowth":0,"percentOfTotal":24.3},{"name":"Cutivate","genericName":"FLUTICASONE PROPIONATE","slug":"fluticasone-propionate","revenue":69000000,"yoyGrowth":0,"percentOfTotal":2.8}],"timeline":[{"date":"1943-01-01","label":"Tussionex Pennkinetic first approved","drug":"Tussionex Pennkinetic","drugSlug":"hydrocodone","type":"approval","sentiment":"positive"},{"date":"1953-01-01","label":"Diamox first approved","drug":"Diamox","drugSlug":"acetazolamide","type":"approval","sentiment":"positive"},{"date":"1979-01-01","label":"Surmontil first approved","drug":"Surmontil","drugSlug":"trimipramine","type":"approval","sentiment":"positive"},{"date":"1982-01-01","label":"Zanosar first approved","drug":"Zanosar","drugSlug":"streptozocin","type":"approval","sentiment":"positive"},{"date":"1984-01-01","label":"Orap first approved","drug":"Orap","drugSlug":"pimozide","type":"approval","sentiment":"positive"},{"date":"1990-01-01","label":"Cutivate first approved","drug":"Cutivate","drugSlug":"fluticasone-propionate","type":"approval","sentiment":"positive"},{"date":"1991-01-01","label":"Cefzil first approved","drug":"Cefzil","drugSlug":"cefprozil","type":"approval","sentiment":"positive"},{"date":"1992-01-01","label":"Zebeta first approved","drug":"Zebeta","drugSlug":"bisoprolol","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Copaxone first approved","drug":"Copaxone","drugSlug":"glatiramer-acetate","type":"approval","sentiment":"positive"},{"date":"2005-01-01","label":"Mycamine first approved","drug":"Mycamine","drugSlug":"micafungin","type":"approval","sentiment":"positive"},{"date":"2006-01-01","label":"Azilect first approved","drug":"Azilect","drugSlug":"rasagiline","type":"approval","sentiment":"positive"},{"date":"2009-01-01","label":"Istodax first approved","drug":"Istodax","drugSlug":"romidepsin","type":"approval","sentiment":"positive"},{"date":"2012-01-01","label":"Synribo first approved","drug":"Synribo","drugSlug":"omacetaxine-mepesuccinate","type":"approval","sentiment":"positive"},{"date":"2016-01-01","label":"Cinqair first approved","drug":"Cinqair","drugSlug":"reslizumab","type":"approval","sentiment":"positive"},{"date":"2017-01-01","label":"Austedo first approved","drug":"Austedo","drugSlug":"deutetrabenazine","type":"approval","sentiment":"positive"},{"date":"2018-01-01","label":"Ajovy first approved","drug":"Ajovy","drugSlug":"fremanezumab","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-08-26","label":"Cutivate patent expiry (Compound)","drug":"Cutivate","drugSlug":"fluticasone-propionate","type":"patent_expiry","sentiment":"negative"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2031-04-04","label":"Cutivate patent expiry (Method of Use)","drug":"Cutivate","drugSlug":"fluticasone-propionate","type":"patent_expiry","sentiment":"negative"},{"date":"2036-02-23","label":"Cutivate patent expiry (Method of Use)","drug":"Cutivate","drugSlug":"fluticasone-propionate","type":"patent_expiry","sentiment":"negative"},{"date":"2041-06-10","label":"Austedo patent expiry (Formulation)","drug":"Austedo","drugSlug":"deutetrabenazine","type":"patent_expiry","sentiment":"negative"},{"date":"2028-06-01","label":"Copaxone patent cliff ($1.4B at risk)","drug":"Copaxone","type":"patent_expiry","sentiment":"negative"},{"date":"2030-06-01","label":"Azilect patent cliff ($400M at risk)","drug":"Azilect","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":1300000000,"percentOfTotal":52.7,"drugCount":7,"colorKey":"immunology","drugs":[{"name":"Copaxone","genericName":"GLATIRAMER ACETATE","slug":"glatiramer-acetate","indication":"Multiple sclerosis","status":"marketed","revenue":700000000},{"name":"Ajovy","genericName":"FREMANEZUMAB","slug":"fremanezumab","indication":"Migraine","status":"marketed","revenue":600000000},{"name":"Nerventra","genericName":"LAQUINIMOD","slug":"laquinimod","indication":"Relapsing remitting multiple sclerosis","status":"discontinued"},{"name":"Trileptal®","genericName":"Trileptal®","slug":"trileptal","indication":"Partial-onset seizures (monotherapy and adjunctive therapy in adults and children)","status":"marketed"},{"name":"Azilect","genericName":"RASAGILINE","slug":"rasagiline","indication":"Parkinson's disease","status":"marketed"},{"name":"Imitrex®","genericName":"Imitrex®","slug":"imitrex","indication":"Acute treatment of migraine with or without aura","status":"marketed"},{"name":"Surmontil","genericName":"TRIMIPRAMINE","slug":"trimipramine","indication":"Depressive disorder","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":1100000000,"percentOfTotal":44.6,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Austedo","genericName":"DEUTETRABENAZINE","slug":"deutetrabenazine","indication":"Chorea associated with Huntington’s disease","status":"marketed","revenue":1100000000},{"name":"AKLIEF®","genericName":"AKLIEF®","slug":"aklief","indication":"Acne vulgaris","status":"marketed"},{"name":"Trifarotene 0.005 % Topical Cream","genericName":"Trifarotene 0.005 % Topical Cream","slug":"trifarotene-0-005-topical-cream","indication":"Acne vulgaris","status":"phase_3"},{"name":"YAZ®","genericName":"YAZ®","slug":"yaz","indication":"Contraception","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":69000000,"percentOfTotal":2.8,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"Cutivate","genericName":"FLUTICASONE PROPIONATE","slug":"fluticasone-propionate","indication":"Allergic asthma","status":"marketed","revenue":69000000},{"name":"Istodax","genericName":"ROMIDEPSIN","slug":"romidepsin","indication":"Cutaneous T-cell lymphoma (CTCL)","status":"marketed"},{"name":"Synribo","genericName":"OMACETAXINE MEPESUCCINATE","slug":"omacetaxine-mepesuccinate","indication":"Chronic myeloid leukemia","status":"marketed"},{"name":"Zanosar","genericName":"STREPTOZOCIN","slug":"streptozocin","indication":"Pancreatic Neuroendocrine Tumor","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"neuroscience","drugs":[{"name":"FEMCON® Fe","genericName":"FEMCON® Fe","slug":"femcon-fe","indication":"Contraception (prevention of pregnancy)","status":"marketed"},{"name":"Orap","genericName":"PIMOZIDE","slug":"pimozide","indication":"Tourette's Disorder","status":"marketed"},{"name":"Activella®","genericName":"Activella®","slug":"activella","indication":"Other","status":"marketed"},{"name":"Azelastine hydrochloride and Fluticasone propionate","genericName":"Azelastine hydrochloride and Fluticasone propionate","slug":"azelastine-hydrochloride-and-fluticasone-propionate","indication":"Other","status":"marketed"},{"name":"Imvexxy","genericName":"Imvexxy","slug":"imvexxy","indication":"Other","status":"marketed"},{"name":"Lamictal®","genericName":"Lamictal®","slug":"lamictal","indication":"Other","status":"marketed"},{"name":"MabThera infusions","genericName":"MabThera infusions","slug":"mabthera-infusions","indication":"Other","status":"phase_1"},{"name":"Paxil®","genericName":"Paxil®","slug":"paxil","indication":"Other","status":"marketed"},{"name":"SHEUR","genericName":"ELAGOLIX, ESTRADIOL AND NORETHINDRONE ACETATE AND ELAGOLIX","slug":"elagolix-estradiol-and-norethindrone-acetate-and-elagolix","indication":"Other","status":"marketed"},{"name":"Zofran®","genericName":"Zofran®","slug":"zofran","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"infectious","drugs":[{"name":"Mycamine","genericName":"MICAFUNGIN","slug":"micafungin","indication":"Candida Peritonitis","status":"marketed"},{"name":"Augmentin®","genericName":"Augmentin®","slug":"augmentin","indication":"Bacterial infections of the ear, nose, and throat","status":"marketed"},{"name":"Cefzil","genericName":"cefprozil","slug":"cefprozil","indication":"Acute Moraxella catarrhalis bronchitis","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"ophthalmology","drugs":[{"name":"Cozaar®","genericName":"Cozaar®","slug":"cozaar","indication":"Hypertension","status":"marketed"},{"name":"Diamox","genericName":"ACETAZOLAMIDE","slug":"acetazolamide","indication":"Edema due to congestive heart failure","status":"marketed"},{"name":"Zebeta","genericName":"BISOPROLOL","slug":"bisoprolol","indication":"Atrial fibrillation","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"rare","drugs":[{"name":"VTAMA®","genericName":"VTAMA®","slug":"vtama","indication":"Plaque psoriasis","status":"marketed"},{"name":"Tapinarof Cream 1%","genericName":"Tapinarof Cream 1%","slug":"tapinarof-cream-1","indication":"Moderate to severe plaque psoriasis","status":"phase_3"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Tussionex Pennkinetic","genericName":"HYDROCODONE","slug":"hydrocodone","indication":"Allergic rhinitis","status":"marketed"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"metabolic","drugs":[{"name":"Cinqair","genericName":"RESLIZUMAB","slug":"reslizumab","indication":"Eosinophilic asthma","status":"marketed"}]}],"pipeline":[{"name":"Austedo","genericName":"DEUTETRABENAZINE","slug":"deutetrabenazine","phase":"marketed","mechanism":"Austedo works by binding to the synaptic vesicular amine transporter, reducing the release of dopamine and other neurotransmitters.","indications":["Chorea associated with Huntington’s disease","Tardive dyskinesia"],"catalyst":""},{"name":"Copaxone","genericName":"GLATIRAMER ACETATE","slug":"glatiramer-acetate","phase":"marketed","mechanism":"Copaxone works by modulating the immune system's response to reduce inflammation in the central nervous system.","indications":["Multiple sclerosis"],"catalyst":""},{"name":"Ajovy","genericName":"FREMANEZUMAB","slug":"fremanezumab","phase":"marketed","mechanism":"Ajovy works by blocking the action of calcitonin gene-related peptide 1 (CGRP1), a molecule involved in pain transmission.","indications":["Migraine","Prevention of migraine attacks"],"catalyst":""},{"name":"Cutivate","genericName":"FLUTICASONE PROPIONATE","slug":"fluticasone-propionate","phase":"marketed","mechanism":"Glucocorticoid receptor","indications":["Allergic asthma","Allergic rhinitis","Asthma management","Atopic dermatitis","Bronchospasm Prevention with COPD"],"catalyst":""},{"name":"AKLIEF®","genericName":"AKLIEF®","slug":"aklief","phase":"marketed","mechanism":"Retinoic acid receptor alpha, Retinoic acid receptor beta, Retinoic acid receptor gamma","indications":["Acne vulgaris"],"catalyst":""},{"name":"FEMCON® Fe","genericName":"FEMCON® Fe","slug":"femcon-fe","phase":"marketed","mechanism":"FEMCON Fe is an oral contraceptive that prevents pregnancy by suppressing ovulation through a combination of ethinyl estradiol and norethindrone, while the ferrous fumarate component replaces iron lost during menstruation.","indications":["Contraception (prevention of pregnancy)","Regulation of menstrual cycle"],"catalyst":""},{"name":"Mycamine","genericName":"MICAFUNGIN","slug":"micafungin","phase":"marketed","mechanism":"ATP-binding cassette sub-family G member 2","indications":["Candida Peritonitis","Candidal septicemia","Candidemia","Candidiasis of the esophagus","Disseminated candidiasis"],"catalyst":""},{"name":"Nerventra","genericName":"LAQUINIMOD","slug":"laquinimod","phase":"discontinued","mechanism":"Nerventra works by modulating the immune system to reduce inflammation in the central nervous system.","indications":["Relapsing remitting multiple sclerosis"],"catalyst":""},{"name":"Orap","genericName":"PIMOZIDE","slug":"pimozide","phase":"marketed","mechanism":"5-hydroxytryptamine receptor 7","indications":["Tourette's Disorder"],"catalyst":""},{"name":"Trifarotene 0.005 % Topical Cream","genericName":"Trifarotene 0.005 % Topical Cream","slug":"trifarotene-0-005-topical-cream","phase":"phase_3","mechanism":"Trifarotene is a retinoic acid receptor gamma (RAR-gamma) agonist that modulates the expression of genes involved in cell differentiation and proliferation.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Trileptal®","genericName":"Trileptal®","slug":"trileptal","phase":"marketed","mechanism":"Oxcarbazepine blocks voltage-gated sodium channels in neuronal membranes, reducing repetitive neuronal firing and stabilizing hyperexcited neural tissue.","indications":["Partial-onset seizures (monotherapy and adjunctive therapy in adults and children)","Generalized tonic-clonic seizures (adjunctive therapy)","Bipolar disorder (off-label use)"],"catalyst":""},{"name":"Tussionex Pennkinetic","genericName":"HYDROCODONE","slug":"hydrocodone","phase":"marketed","mechanism":"Tussionex Pennkinetic works by binding to opioid receptors in the brain, which helps to reduce pain and congestion.","indications":["Allergic rhinitis","Common cold","Cough","Nasal congestion","Nasal discharge"],"catalyst":""},{"name":"VTAMA®","genericName":"VTAMA®","slug":"vtama","phase":"marketed","mechanism":"VTAMA is a topical retinoid that binds to and activates retinoid X receptors (RXR) to promote skin cell differentiation and reduce inflammation in psoriasis.","indications":["Plaque psoriasis"],"catalyst":""},{"name":"Activella®","genericName":"Activella®","slug":"activella","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Augmentin®","genericName":"Augmentin®","slug":"augmentin","phase":"marketed","mechanism":"Augmentin combines amoxicillin (a beta-lactam antibiotic) with clavulanic acid (a beta-lactamase inhibitor) to kill bacteria and overcome antibiotic resistance.","indications":["Bacterial infections of the ear, nose, and throat","Respiratory tract infections","Urinary tract infections","Skin and soft tissue infections","Bone and joint infections"],"catalyst":""},{"name":"Azelastine hydrochloride and Fluticasone propionate","genericName":"Azelastine hydrochloride and Fluticasone propionate","slug":"azelastine-hydrochloride-and-fluticasone-propionate","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Azilect","genericName":"RASAGILINE","slug":"rasagiline","phase":"marketed","mechanism":"5-hydroxytryptamine receptor 6","indications":["Parkinson's disease"],"catalyst":""},{"name":"Cefzil","genericName":"cefprozil","slug":"cefprozil","phase":"marketed","mechanism":"Small molecule","indications":["Acute Moraxella catarrhalis bronchitis","Acute bacterial bronchitis","Acute bacterial sinusitis","Acute exacerbation of chronic bronchitis","Acute otitis media"],"catalyst":""},{"name":"Cinqair","genericName":"RESLIZUMAB","slug":"reslizumab","phase":"marketed","mechanism":"Cinqair works by blocking the action of interleukin-5, a protein that promotes the production of eosinophils, which contribute to inflammation in the airways.","indications":["Eosinophilic asthma"],"catalyst":""},{"name":"Cozaar®","genericName":"Cozaar®","slug":"cozaar","phase":"marketed","mechanism":"Cozaar blocks angiotensin II receptors on blood vessels and tissues, causing vasodilation and reducing blood pressure.","indications":["Hypertension","Diabetic nephropathy in patients with type 2 diabetes","Heart failure with reduced ejection fraction","Stroke risk reduction in hypertensive patients with left ventricular hypertrophy"],"catalyst":""},{"name":"Diamox","genericName":"ACETAZOLAMIDE","slug":"acetazolamide","phase":"marketed","mechanism":"Carbonic anhydrase","indications":["Edema due to congestive heart failure","Drug-induced edema","Centrencephalic epilepsies","Chronic simple (open-angle) glaucoma","Secondary glaucoma"],"catalyst":""},{"name":"Imitrex®","genericName":"Imitrex®","slug":"imitrex","phase":"marketed","mechanism":"Imitrex is a selective serotonin 5-HT1B/1D receptor agonist that constricts cranial blood vessels and inhibits neuropeptide release to relieve migraine headaches.","indications":["Acute treatment of migraine with or without aura","Acute treatment of cluster headache"],"catalyst":""},{"name":"Imvexxy","genericName":"Imvexxy","slug":"imvexxy","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Istodax","genericName":"ROMIDEPSIN","slug":"romidepsin","phase":"marketed","mechanism":"Romidepsin inhibits HDACs, leading to increased acetylation of histones and non-histone proteins, causing cell cycle arrest and apoptosis in cancer cells.","indications":["Cutaneous T-cell lymphoma (CTCL)"],"catalyst":""},{"name":"Lamictal®","genericName":"Lamictal®","slug":"lamictal","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MabThera infusions","genericName":"MabThera infusions","slug":"mabthera-infusions","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Paxil®","genericName":"Paxil®","slug":"paxil","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SHEUR","genericName":"ELAGOLIX, ESTRADIOL AND NORETHINDRONE ACETATE AND ELAGOLIX","slug":"elagolix-estradiol-and-norethindrone-acetate-and-elagolix","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"Surmontil","genericName":"TRIMIPRAMINE","slug":"trimipramine","phase":"marketed","mechanism":"Histamine H1 receptor","indications":["Depressive disorder"],"catalyst":""},{"name":"Synribo","genericName":"OMACETAXINE MEPESUCCINATE","slug":"omacetaxine-mepesuccinate","phase":"marketed","mechanism":"Small molecule","indications":["Chronic myeloid leukemia"],"catalyst":""},{"name":"Tapinarof Cream 1%","genericName":"Tapinarof Cream 1%","slug":"tapinarof-cream-1","phase":"phase_3","mechanism":"Tapinarof is a topical aryl hydrocarbon receptor agonist that modulates the immune response and reduces inflammation.","indications":["Moderate to severe plaque psoriasis"],"catalyst":""},{"name":"YAZ®","genericName":"YAZ®","slug":"yaz","phase":"marketed","mechanism":"YAZ is an oral contraceptive that prevents ovulation through a combination of ethinyl estradiol (estrogen) and drospirenone (progestin), while drospirenone also provides antimineralocorticoid activity.","indications":["Contraception","Acne vulgaris (FDA-approved indication)","Premenstrual dysphoric disorder (PMDD)"],"catalyst":""},{"name":"Zanosar","genericName":"STREPTOZOCIN","slug":"streptozocin","phase":"marketed","mechanism":"Small molecule","indications":["Pancreatic Neuroendocrine Tumor"],"catalyst":""},{"name":"Zebeta","genericName":"BISOPROLOL","slug":"bisoprolol","phase":"marketed","mechanism":"Beta-1 adrenergic receptor","indications":["Atrial fibrillation","Hypertensive disorder"],"catalyst":""},{"name":"Zofran®","genericName":"Zofran®","slug":"zofran","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Teva Pharmaceutical Reports Fourth Quarter and Full Year 2023 Results","summary":"Teva reported a net loss of $1.1 billion for the fourth quarter and $3.4 billion for the full year 2023.","drugName":"","sentiment":"negative"},{"date":"2023-11-15","type":"deal","headline":"Teva Pharmaceutical to Sell US Generic Business to Sandoz for $3.45 Billion","summary":"Teva agreed to sell its US generic business to Sandoz for $3.45 billion.","drugName":"","sentiment":"neutral"},{"date":"2023-08-01","type":"regulatory","headline":"FDA Approves Teva's Generic Version of Copaxone","summary":"The FDA approved Teva's generic version of Copaxone, a multiple sclerosis treatment.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPc0VSQ01SQmJfaTVWTVVCTzcwbnd5ZVl5LVg5enJDd3lpYnlHMjUxZG50REdjTmV6RlJkTTIxbXpCTnBhQVVxRl95dWZGZkI4S3RuM2s0Z3U2YWl4LVNPUVRQeTVGN3lRQi1Eb0ZEU2lrUVVvb1Ita3IzRUdvSUtaQmpBTXIxM0txdFgzdHgzVF9LRUVrdzB3RmxkQ1M3cXZ0Tzh3MUNkNU1fZWs0UTRGcWJMRGZMaUo4RFVMZy1kQVA3Y3hISW94MlVsRzVVLXVyQ2FiYm01NGMxekNENWRJUXRqS0FhTEN0?oc=5","date":"2026-04-08","type":"deal","source":"MarketBeat","summary":"Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives Consensus Rating of \"Moderate Buy\" from Analysts - MarketBeat","headline":"Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives Consensus Rating of \"Moderate Buy\" from Analysts","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-07","type":"earnings","source":"Insider Monkey","summary":"Factors Supporting Teva Pharmaceutical’s (TEVA) Long-Term Profitability - Insider Monkey","headline":"Factors Supporting Teva Pharmaceutical’s (TEVA) Long-Term Profitability","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOd05IaGJqa3NrM1VNWkQ5R1h1Qm03VlB5RVZuUkIycDRzcGtUWG15Zzd5cC1ZZXBpUXNINkhIaW5IRE41aXh1bVBZRzdzWFI2dF90cTBnTDA5TjZpN004Nm9jd2VNc3NkeF9yNHY1eTVERUFkaXpjaDlXLXpMTmJaRDZaMFc1VHM0MWZ2Ym9XOGhwNzNISkNVLThCcmtwLUtRZWRzTG52c1MtUklaY2tvTFpINXJmQXloekdKc21SX3VvUFFwaHhDZg?oc=5","date":"2026-04-06","type":"pipeline","source":"MarketBeat","summary":"Teva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Down - Here's What Happened - MarketBeat","headline":"Teva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Down - Here's What Happened","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-04","type":"regulatory","source":"simplywall.st","summary":"How Investors Are Reacting To Teva (TEVA) Advancing Its Biosimilar Pipeline With New FDA and EMA Milestones - simplywall.st","headline":"How Investors Are Reacting To Teva (TEVA) Advancing Its Biosimilar Pipeline With New FDA and EMA Milestones","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNbzJHMTZIR3gzU1QxTUEzQXJoc0NHWDlzU2lQLUphTTJVaFhiNEFKeXRnXzZoTlQ2eDdRU2ttbWhZUi1iWEJabHU5dDF5eDRYR3hKaGlPYU0zV3hyZ2l5UmRDaG1GOTJ6M0JZMWE0NmJGVDVQcmF3SWVaamtoMmpHTV9DZzk5TFZTdzNyWE9LRGQzOVR5Y1gxbVNnZW5oYUpJRHZIVw?oc=5","date":"2026-04-02","type":"pipeline","source":"Chief Healthcare Executive","summary":"Iran war and drug supplies: Don’t panic, but pay attention - Chief Healthcare Executive","headline":"Iran war and drug supplies: Don’t panic, but pay attention","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-01","type":"patent","source":"simplywall.st","summary":"Missile Strike Near Teva Site Tests Supply Resilience And Biosimilar Growth Plans - simplywall.st","headline":"Missile Strike Near Teva Site Tests Supply Resilience And Biosimilar Growth Plans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOeEJfdWgzTTBiT1lMeUxJeVQ4ZXZGdmV1OTFRd1QtOTE2LVlIR1A2VmFTSUh4UnlLaGViZ3JBSFlRVHN5NVlPMzczX014UGRocnZLWXU4bkRQdmwtbGZCRlJrd2tXVUl1dGtZMDVmU0NHY21ZM1MyNDVEUVQycF9yMmUwa1RVSWVGMzNka2N5aGR6Q1FEZ0hJWHdpenhGZi1yVVVHcFpUTzI0d0JiSzZtaUk1ZWQzOGhScjU5SDdWcVgyV1hjeU12YkxpQXdrdDlWU3c?oc=5","date":"2026-03-19","type":"earnings","source":"Quiver Quantitative","summary":"Teva Pharmaceutical Industries Ltd. to Release First Quarter 2026 Financial Results on April 29, 2026 - Quiver Quantitative","headline":"Teva Pharmaceutical Industries Ltd. to Release First Quarter 2026 Financial Results on April 29, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPWGxqUFozX2lPLVh4QXNRbndLOFRYMWw3ZXQ4bmktSlRUWVZiV3FLRzIzSVRSVG9uOFVNbXo0V3dHZGlpU2V1SFFYNkhib3p6S3B1eDNNZkh6RGhYQVEydU1NZU1sZkQtVUZzV0dpSGJRV0ZnOWJhN2RQS3N4RU1zcTVCeDJfUVNwbVd1dHg4aw?oc=5","date":"2026-03-15","type":"deal","source":"Yahoo Finance","summary":"Is Teva Pharmaceutical Industries (TEVA) A Good Stock To Buy Now? - Yahoo Finance","headline":"Is Teva Pharmaceutical Industries (TEVA) A Good Stock To Buy Now?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQMEZhNVgyVUJmSThzUFdwTTQyelJZUjhELUJrWG9ZNGJnaG16YzhPTm5abTJXV05EZDF0Z1Q0ZGtqVlhtSVJwTnN3azZTMG5VNjFYMEJEejhnWl9EWnpNczdCdFBlank4d050VWtYcUhxMVFyZmw4Z1NabjZnRjdrYU5LX0tuc0lnN016MHp3VG1VV0E?oc=5","date":"2026-03-15","type":"pipeline","source":"Yahoo Finance","summary":"Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its 75% One Year Rally? - Yahoo Finance","headline":"Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its 75% One Year Rally?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQbHBwT2dTODNESXBIZnRYX09VdUJaeWFBdXVuY2hSSDZIMkY0QzdjQ2VkT0Z6dktjNXNPTTFWbUN6QXBhOHNoeEw0cGhKWGpMTjhaS1ZIaWNWYy16a25XdGkwZ3FvQThwb241OG9BRVQweEF6SERvb0d2YUVvYWpDdVZTY3UtNTNUOGp1cXJmTlVNSTJWTzhZX3BfMzg4UQ?oc=5","date":"2026-03-04","type":"pipeline","source":"BioPharma Dive","summary":"Blackstone puts $400M into Teva, Sanofi gut disease drug - BioPharma Dive","headline":"Blackstone puts $400M into Teva, Sanofi gut disease drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNTm9RcVFZWWZ2T3NXYzZ6RklSVzRTZ2x4SlZtMXQ4VUtFUHVtc25zNllPWXhFVDVjSDJTaEFQeU1HUUlfQ1dqQnhadkJvbDBSa2VmeVFnZ3hweVFGeTFNMGpsVmVoMDlsaDVaeEZNaml5WGpsbDJYQkJyTFVELUJGOFZqUEFuR1ZBVWlvY0hXZWlBT2YtMTVUOHRvVGJaenB3NnRlU2dNTzI4Q1d2M2NuazNRY0oxZDI3SGdHUUwwUG1fZGZ6?oc=5","date":"2026-01-28","type":"earnings","source":"Reuters","summary":"Teva Pharmaceutical Q4 profit gains as branded drugs aid transition from generics - Reuters","headline":"Teva Pharmaceutical Q4 profit gains as branded drugs aid transition from generics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNUkdiOENaZk5FZWRZSTlkcmtiRzdIS2JmV3JVYUwzbUU0eVl3WW5hNkcwX0JULVViMmp1d1UyaG5VRUFwWFQ0SVVWOE5kV1lJeHdXQzdXZDEwWU50UjFFblhySGRhZDcwUEMyWFFlNkpvdnFOS0hDZ2t4R2U0TzkyV0M2Ym93VXRhWWdFbFBBM3NyNjdzaV9ObHZQY3Q0OEVsb0E?oc=5","date":"2026-01-28","type":"pipeline","source":"Fierce Pharma","summary":"Teva, after 3rd straight year of growth, expects downturn in 2026 - Fierce Pharma","headline":"Teva, after 3rd straight year of growth, expects downturn in 2026","sentiment":"neutral"}],"patents":[{"drugName":"Cutivate","drugSlug":"fluticasone-propionate","patentNumber":"7500444","type":"Formulation","expiryDate":"2026-02-26","territory":"US","annualRevenue":69000000,"genericFilings":[]},{"drugName":"Cutivate","drugSlug":"fluticasone-propionate","patentNumber":"7500444*PED","type":"Compound","expiryDate":"2026-08-26","territory":"US","annualRevenue":69000000,"genericFilings":[]},{"drugName":"Copaxone","drugSlug":"glatiramer-acetate","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":1400000000},{"drugName":"Azilect","drugSlug":"rasagiline","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":400000000},{"drugName":"Cutivate","drugSlug":"fluticasone-propionate","patentNumber":"12083270","type":"Method of Use","expiryDate":"2031-04-04","territory":"US","annualRevenue":69000000,"genericFilings":[]},{"drugName":"Cutivate","drugSlug":"fluticasone-propionate","patentNumber":"11554229","type":"Method of Use","expiryDate":"2036-02-23","territory":"US","annualRevenue":69000000,"genericFilings":[]},{"drugName":"Austedo","drugSlug":"deutetrabenazine","patentNumber":"11311488","type":"Formulation","expiryDate":"2041-06-10","territory":"US","annualRevenue":1100000000,"genericFilings":[]}],"drugCount":35,"phaseCounts":{"marketed":31,"discontinued":1,"phase_3":2,"phase_1":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Pfizer","Novartis","Merck & Co."],"therapeuticFocus":["Respiratory","Central Nervous System","Oncology"],"financials":{"source":"sec_edgar","revenue":1500000000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":1500000000,"period":"2025-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":98000000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":1410000000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":40748000000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":30.2,"previousClose":29.33,"fiftyTwoWeekHigh":37.35,"fiftyTwoWeekLow":12.47,"fiftyTwoWeekRange":"12.47 - 37.35","fiftyDayAverage":32.1,"twoHundredDayAverage":24.44,"beta":0.76,"enterpriseValue":47402012672,"forwardPE":9.8,"priceToBook":4.39,"priceToSales":2.09,"enterpriseToRevenue":2.75,"enterpriseToEbitda":9.57,"pegRatio":1.48,"ebitda":4953999872,"ebitdaMargin":28.7,"freeCashflow":2031500032,"operatingCashflow":1648999936,"totalDebt":17230000128,"debtToEquity":217.7,"currentRatio":1.04,"returnOnAssets":6.2,"returnOnEquity":20.8,"analystRating":"1.5 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":11,"targetMeanPrice":37.82,"targetHighPrice":45,"targetLowPrice":28,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":2.95,"exDividendDate":1511740800,"insiderHeldPercent":0,"institutionHeldPercent":60.2,"sharesOutstanding":1164403205,"floatShares":1069406482,"sharesShort":37623025,"shortRatio":4.99,"shortPercentOfFloat":3.2,"epsTrailing":1.21,"epsForward":3.09,"revenuePerShare":15.07,"bookValue":6.88,"officers":[{"age":57,"name":"Mr. Richard D. Francis","title":"President, CEO & Director"},{"age":51,"name":"Mr. Eliyahu Sharon Kalif","title":"Executive VP & CFO"},{"age":50,"name":"Mr. Matthew  Shields","title":"Executive Vice President of Global Operations"},{"age":48,"name":"Mr. Amir  Weiss","title":"Senior VP & Chief Accounting Officer"},{"age":null,"name":"Mr. Christopher J. Stevo CFA","title":"Senior Vice President of Investor Relations & Competitive Intelligence"},{"age":null,"name":"Kathleen  Veit","title":"Senior Vice President, Global Compliance & Ethics Officer"},{"age":null,"name":"Mr. Brian  Savage","title":"Interim Chief Legal Officer"},{"age":43,"name":"Mr. Placid  Jover","title":"Executive VP & CHRO"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.tevapharm.com","phone":"972 3 914 8213"}}